Quintessence Biotech is developing DACS™ (Droplet Activated Cell Sorting), a patented technology based on functionalized biomimetic lipid droplets, enabling advanced bio-separation and cellular bio-activation processes.
Our platform relies on a flotation-based bio-separation principle, a gentle and efficient approach that provides an alternative to magnetic separation technologies, reducing mechanical stress and simplifying cell handling processes.
Depending on the use case, our patented particles can also enable the biomimetic activation of cells of interest, reproducing natural biological interactions. This approach promotes the production of higher-quality biopharmaceuticals, particularly in the field of cell and gene therapies, by improving the functional profile and performance of the cells produced.
At the interface of immunology, colloidal engineering and bioproduction, Quintessence Biotech is developing solutions designed to accelerate research, preclinical development and the manufacturing of new cell therapies.
